The main purpose of this study is to find out how many people in Spain have been diagnosed with narcolepsy type 1 and type 2, and how many new participants are diagnosed each year. Narcolepsy is a rare sleep disorder that causes excessive daytime sleepiness. The researchers will look at medical records from hospitals across Spain to count participants with these conditions and understand patterns in diagnosis over time.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Core Group: Prevalence of Participants With NT1 and NT2 per 100,000 Population
Timeframe: Up to 1 year
Core Group: Prevalence of Adult Participants With NT1 and NT2 per 100,000 Adult Population
Timeframe: Up to 1 year
Core Group: Prevalence of Paediatric/Adolescent Participants With NT1 and NT2 per 100,000 Paediatric/Adolescent Population
Timeframe: Up to 1 year
Core Group: Prevalence of Male Participants With NT1 and NT2 per 100,000 Male Population
Timeframe: Up to 1 year
Core Group: Prevalence of Female Participants With NT1 and NT2 per 100,000 Females Population
Timeframe: Up to 1 year
Core Group: Incidence of NT1 and NT2 per 100,000 Population
Timeframe: Up to 2 years
Core Group: Incidence of NT1 and NT2 per 100,000 Adult Population
Timeframe: Up to 2 years
Core Group: Incidence of Paediatric/Adolescent NT1 and NT2 per 100,000 Paediatric/Adolescent Population
Timeframe: Up to 2 years
Core Group: Incidence of Male NT1 and NT2 per 100,000 Male Population
Timeframe: Up to 2 years
Core Group: Incidence of Female NT1 and NT2 per 100,000 Female Population
Timeframe: Up to 2 years
Supplementary Group: Number of Participants with NT1 and NT2 who Attend Regular Follow-ups
Timeframe: On a day of survey (any 1 day) during the study for each participant